Role of osteopontin in cellular signaling and toxicant injury.

Osteopontin (OPN) is a glycosylated phosphoprotein found in all body fluids and in the proteinaceous matrix of mineralized tissues. It can function both as a cell attachment protein and as a cytokine, delivering signals to cells via a number of receptors including several integrins and CD44. Expression of OPN is enhanced by a variety of toxicants, especially those that activate protein kinase C. In its capacity as a signaling molecule, OPN can modify gene expression and promote the migration of monocytes/macrophages up an OPN gradient. It has both inflammatory and anti-inflammatory actions. Some experiments suggest that it may inhibit apoptosis, possibly contributing to the survival of cells in response to toxicant injury. Elevated OPN expression often correlates with malignancy and has been shown to enhance the tumorigenic and/or metastatic phenotype of the cancer cell. Recent studies have revealed that OPN plays critical roles in bone remodeling and cell-mediated immunity.

[1]  R. Hynes,et al.  Transformed mammalian cells secrete specific proteins and phosphoproteins , 1979, Cell.

[2]  H. Dvorak,et al.  A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells , 1983, Nature.

[3]  D. Denhardt,et al.  Molecular cloning of a tumor promoter‐inducible mRNA found in JB6 mouse epidermal cells: Induction is stable at high, but not at low, cell densities , 1987, Journal of cellular biochemistry.

[4]  D. Tenen,et al.  Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation. , 1988, Cancer research.

[5]  F. Blattner,et al.  Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene. Definition of a novel T cell-dependent response associated with genetic resistance to bacterial infection , 1989, The Journal of experimental medicine.

[6]  H. Cantor,et al.  Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo , 1990, The Journal of experimental medicine.

[7]  H. Cantor,et al.  Polyclonal B cell activation by the Eta-1 cytokine and the development of systemic autoimmune disease. , 1991, Journal of immunology.

[8]  S. Colucci,et al.  Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts. , 1991, The Journal of biological chemistry.

[9]  S. Schwartz,et al.  Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). , 1991, Biochemical and biophysical research communications.

[10]  M. C. Farach-Carson,et al.  Evidence for the formation of a complex between osteopontin and osteocalcin , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  E. Manseau,et al.  Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. , 1992, Molecular biology of the cell.

[12]  A. Zallone,et al.  Immediate cell signal by bone-related peptides in human osteoclast-like cells. , 1993, The American journal of physiology.

[13]  A. Chambers,et al.  Inhibition of Arg-Gly-Asp (RGD)-mediated cell adhesion to osteopontin by a monoclonal antibody against osteopontin. , 1994, The Journal of biological chemistry.

[14]  M. Inobe,et al.  In vivo cytokine gene expression in various T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse. , 1994, Autoimmunity.

[15]  S M Schwartz,et al.  Macrophages express osteopontin during repair of myocardial necrosis. , 1994, The American journal of pathology.

[16]  D. Cheresh,et al.  Requirement of vascular integrin alpha v beta 3 for angiogenesis. , 1994, Science.

[17]  T. Yue,et al.  Osteopontin-stimulated vascular smooth muscle cell migration is mediated by beta 3 integrin. , 1994, Experimental cell research.

[18]  D. Laskin,et al.  Osteopontin inhibits induction of nitric oxide synthase gene expression by inflammatory mediators in mouse kidney epithelial cells. , 1994, The Journal of biological chemistry.

[19]  E. Manseau,et al.  Osteopontin expression and distribution in human carcinomas. , 1994, The American journal of pathology.

[20]  L. Schook,et al.  Xenobiotics and inflammation , 1994 .

[21]  B. Berse,et al.  Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts. , 1994, Oncogene.

[22]  S. Schwartz,et al.  Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. , 1994, Circulation research.

[23]  B. Aggarwal,et al.  The p60 Tumor Necrosis Factor (TNF) Receptor-associated Kinase (TRAK) Binds Residues 344–397 within the Cytoplasmic Domain Involved in TNF Signaling (*) , 1995, The Journal of Biological Chemistry.

[24]  S. Schwartz,et al.  Molecular and cellular biology of osteopontin Potential role in cardiovascular disease. , 1995, Trends in cardiovascular medicine.

[25]  T. Ishida,et al.  Expression of wild-type and mutated rabbit osteopontin in Escherichia coli, and their effects on adhesion and migration of P388D1 cells. , 1995, The Biochemical journal.

[26]  V. Castronovo,et al.  Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. , 1995, The American journal of pathology.

[27]  S. Hirota,et al.  Expression of bone matrix protein messenger ribonucleic acids in human breast cancers. Possible involvement of osteopontin in development of calcifying foci. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[28]  L. Su,et al.  Expression of antisense osteopontin RNA inhibits tumor promoter-induced neoplastic transformation of mouse JB6 epidermal cells. , 1995, Oncogene.

[29]  Shiaw-Min Hwang,et al.  Osteopontin‐Induced Modifications of Cellular Functions a , 1995, Annals of the New York Academy of Sciences.

[30]  S. Schwartz,et al.  Osteopontin and beta 3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro. , 1995, Circulation research.

[31]  J. Balligand,et al.  Glucocorticoids Increase Osteopontin Expression in Cardiac Myocytes and Microvascular Endothelial Cells , 1995, The Journal of Biological Chemistry.

[32]  R. Ross,et al.  The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. , 1995, The Journal of clinical investigation.

[33]  M. McKee,et al.  Secretion of osteopontin by macrophages and its accumulation at tissue surfaces during wound healing in mineralized tissues: A potential requirement for macrophage adhesion and phagocytosis , 1996, The Anatomical record.

[34]  D. Cheresh,et al.  Osteopontin activation of c-src in human melanoma cells requires the cytoplasmic domain of the integrin alpha v-subunit. , 1996, Endocrinology.

[35]  A. Oates,et al.  The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. , 1996, Oncogene.

[36]  B. Padanilam,et al.  Insulin-like growth factor I-enhanced renal expression of osteopontin after acute ischemic injury in rats. , 1996, Endocrinology.

[37]  M. McKee,et al.  Osteopontin at mineralized tissue interfaces in bone, teeth, and osseointegrated implants: Ultrastructural distribution and implications for mineralized tissue formation, turnover, and repair , 1996, Microscopy research and technique.

[38]  D. Laskin,et al.  Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW264.7 macrophages , 1996, Journal of leukocyte biology.

[39]  D. Sheppard,et al.  Osteopontin N-terminal Domain Contains a Cryptic Adhesive Sequence Recognized by α9β1 Integrin* , 1996, The Journal of Biological Chemistry.

[40]  Toshitaka Nakamura,et al.  Changes in biological activity of bone cells in ovariectomized rats revealed by in situ hybridization , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[41]  M. Detmar,et al.  Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. , 1996, The American journal of pathology.

[42]  J. Paulauskis,et al.  Differential screening identifies genetic markers of monocyte to macrophage maturation , 1996, Journal of leukocyte biology.

[43]  M. Glimcher,et al.  Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1) , 1996, Science.

[44]  K. Hruska,et al.  Osteopontin stimulates gelsolin-associated phosphoinositide levels and phosphatidylinositol triphosphate-hydroxyl kinase. , 1996, Molecular biology of the cell.

[45]  S. Rittling,et al.  Osteopontin expression in mammary gland development and tumorigenesis. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[46]  J. Robb,et al.  Electrophysiological Responses of Human Bone Cells to Mechanical Stimulation: Evidence for Specific Integrin Function in Mechanotransduction , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[47]  R. Johnson,et al.  Osteopontin in chronic puromycin aminonucleoside nephrosis. , 1997, Journal of the American Society of Nephrology : JASN.

[48]  K. Ramos,et al.  Differential processing of osteopontin characterizes the proliferative vascular smooth muscle cell phenotype induced by allylamine , 1997, Journal of cellular biochemistry.

[49]  S. Teitelbaum,et al.  Osteoclasts, macrophages, and the molecular mechanisms of bone resorption , 1997, Journal of leukocyte biology.

[50]  T. Martin,et al.  Calcitonin receptors, bone sialoprotein and osteopontin are expressed in primary breast cancers , 1997, International journal of cancer.

[51]  F. O'Malley,et al.  Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[52]  J. Klein-Nulend,et al.  Mechanical stimulation of osteopontin mRNA expression and synthesis in bone cell cultures , 1997, Journal of cellular physiology.

[53]  A. Oates,et al.  Isolation of and effector for metastasis-inducing DNAs from a human metastatic carcinoma cell line , 1997, Oncogene.

[54]  M. Tsao,et al.  ras mutation and expression of the ras‐regulated genes osteopontin and cathepsin L in human esophageal cancer , 1997, International journal of cancer.

[55]  Hiroshi Sato,et al.  Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors , 1997 .

[56]  M. Murakami,et al.  Osteopontin, a Coordinator of Host Defense System: a Cytokine or an Extracellular Adhesive Protein? , 1997, Microbiology and immunology.

[57]  H. Wu,et al.  Upregulation of osteopontin in ischemia-induced renal failure in rats: a role for ET-1? , 1997, Biochemical and biophysical research communications.

[58]  R. Young,et al.  A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[59]  S. Schwartz,et al.  Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[60]  S. Manolagas,et al.  Osteopontin expression by osteoclast and osteoblast progenitors in the murine bone marrow: demonstration of its requirement for osteoclastogenesis and its increase after ovariectomy. , 1997, Endocrinology.

[61]  V. Sondak,et al.  Type 1 versus type 2 cytokine release by Vbeta T cell subpopulations determines in vivo antitumor reactivity: IL-10 mediates a suppressive role. , 1997, Journal of immunology.

[62]  G. Rodan Control of bone formation and resorption: biological and clinical perspective. , 1998, Journal of cellular biochemistry. Supplement.

[63]  C. McCulloch,et al.  Analysis of intracellular osteopontin as a marker of osteoblastic cell differentiation and mesenchymal cell migration. , 1998, European journal of oral sciences.

[64]  J. M. Scholtz,et al.  Osteopontin is a ligand for the alpha4beta1 integrin. , 1998, Journal of cell science.

[65]  R. Kreisberg,et al.  Regulation of proximal tubular osteopontin in experimental hydronephrosis in the rat. , 1998, Kidney international.

[66]  R. Jilka,et al.  Cytokines, bone remodeling, and estrogen deficiency: a 1998 update. , 1998, Bone.

[67]  K. Hruska,et al.  c-Src Is Required for Stimulation of Gelsolin-associated Phosphatidylinositol 3-Kinase* , 1998, The Journal of Biological Chemistry.

[68]  J. F. Harris,et al.  Osteopontin expression in a group of lymph node negative breast cancer patients , 1998, International journal of cancer.

[69]  N. Fausto,et al.  NF-κB Mediates αvβ3 Integrin-induced Endothelial Cell Survival , 1998, The Journal of cell biology.

[70]  H. Blair How the osteoclast degrades bone , 1998, BioEssays : news and reviews in molecular, cellular and developmental biology.

[71]  C. Murry,et al.  Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. , 1998, The American journal of pathology.

[72]  T. Martin,et al.  Casein kinase 2 phosphorylation of recombinant rat osteopontin enhances adhesion of osteoclasts but not osteoblasts , 1998, Journal of cellular physiology.

[73]  D. Lt,et al.  Integrin-mediated Signaling in the Regulation of Osteoclast Adhesion and Activation , 1998 .

[74]  B. Hogan,et al.  Altered wound healing in mice lacking a functional osteopontin gene (spp1). , 1998, The Journal of clinical investigation.

[75]  M. McKee,et al.  Mice Lacking Osteopontin Show Normal Development and Bone Structure but Display Altered Osteoclast Formation In Vitro , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[76]  R. Wüthrich,et al.  Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis. , 1998, Autoimmunity.

[77]  T. Yue,et al.  Delayed Expression of Osteopontin after Focal Stroke in the Rat , 1998, The Journal of Neuroscience.

[78]  A. Chambers,et al.  Osteopontin inhibits inducible nitric oxide synthase activity in rat vascular tissue. , 1998, The American journal of physiology.

[79]  H. Yokozaki,et al.  Co‐expression of osteopontin and CD44v9 in gastric cancer , 1998, International journal of cancer.

[80]  M. Noda,et al.  Osteopontin expression and function: Role in bone remodeling , 1998, Journal of cellular biochemistry. Supplement.

[81]  L. Matrisian,et al.  Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo. , 1998, Cancer research.

[82]  R. Atkins,et al.  A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat. , 1998, Proceedings of the Association of American Physicians.

[83]  C. Gilles,et al.  The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype. , 1998, Experimental cell research.

[84]  D. Cheresh,et al.  The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. , 1999, The Journal of clinical investigation.

[85]  G D Roodman,et al.  Cell biology of the osteoclast. , 1999, Experimental hematology.

[86]  Y. Kitamura,et al.  Role of Osteopontin in Bone Remodeling Caused by Mechanical Stress , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[87]  L. Gerstenfeld Osteopontin in Skeletal Tissue Homeostasis: An Emerging Picture of the Autocrine/Paracrine Functions of the Extracellular Matrix , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[88]  M. Colombo,et al.  Interleukin-12 as an adjuvant for cancer immunotherapy. , 1999, Methods.

[89]  C. Alpers,et al.  Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. , 1999, Kidney international.

[90]  J. Klein-Nulend,et al.  MECHANOTRANSDUCTION IN BONE : ROLE OF THE LACUNOCANALICULAR NETWORK , 1999 .

[91]  E. Thompson,et al.  Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer. , 1999, Laboratory investigation; a journal of technical methods and pathology.

[92]  R. Young,et al.  Attenuated Host Resistance againstMycobacterium bovis BCG Infection in Mice Lacking Osteopontin , 1999, Infection and Immunity.

[93]  H. Maguire,et al.  Tumor-induced interleukin-10 inhibits type 1 immune responses directed at a tumor antigen as well as a non-tumor antigen present at the tumor site. , 1999, Cancer research.

[94]  J. Sleeman,et al.  CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. , 1999, Cancer research.

[95]  S. Abe,et al.  Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma. , 1999, American journal of respiratory and critical care medicine.

[96]  G. Chupp,et al.  Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. , 1999, Journal of immunology.

[97]  K. Yokote,et al.  Enhanced expression of osteopontin by high glucose in cultured rat aortic smooth muscle cells. , 1999, Biochemical and Biophysical Research Communications - BBRC.

[98]  J. Cha,et al.  Transient upregulation of osteopontin mRNA in hippocampus and striatum following global forebrain ischemia in rats , 1999, Neuroscience Letters.

[99]  M. C. Ling,et al.  Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells , 1999, Oncogene.

[100]  M D McKee,et al.  Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. , 1999, Circulation research.

[101]  H. Ikeda,et al.  Expression of osteopontin in Kupffer cells and hepatic macrophages and Stellate cells in rat liver after carbon tetrachloride intoxication: a possible factor for macrophage migration into hepatic necrotic areas. , 1999, Biochemical and biophysical research communications.

[102]  M Noda,et al.  Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[103]  A. Chambers,et al.  Reduced tolerance to acute renal ischemia in mice with a targeted disruption of the osteopontin gene. , 1999, Kidney international.

[104]  A. Aruffo,et al.  CD44 is not an adhesive receptor for osteopontin , 1999, Journal of cellular biochemistry.

[105]  D. Sheppard,et al.  The Integrin α9β1 Binds to a Novel Recognition Sequence (SVVYGLR) in the Thrombin-cleaved Amino-terminal Fragment of Osteopontin* , 1999, The Journal of Biological Chemistry.

[106]  P. Mäenpää,et al.  Cross-linking of Osteopontin by Tissue Transglutaminase Increases Its Collagen Binding Properties* , 1999, The Journal of Biological Chemistry.

[107]  R. Atkins,et al.  IL-1 up-regulates osteopontin expression in experimental crescentic glomerulonephritis in the rat. , 1999, The American journal of pathology.

[108]  D. Denhardt,et al.  Osteopontin Function in Pathology: Lessons from Osteopontin-Deficient Mice , 1999, Nephron Experimental Nephrology.

[109]  M. D. de Broe,et al.  Differences in osteopontin up-regulation between proximal and distal tubules after renal ischemia/reperfusion. , 1999, Kidney international.

[110]  M. Nangaku,et al.  Complement membrane attack complex (C5b-9) mediates interstitial disease in experimental nephrotic syndrome. , 1999, Journal of the American Society of Nephrology : JASN.

[111]  A. Chambers,et al.  The Role of Osteopontin in the Development of Granulomatous Lesions in Lung , 2000, Microbiology and immunology.

[112]  R. Kalluri,et al.  Osteopontin expressed by renal tubular epithelium mediates interstitial monocyte infiltration in rats. , 2000, American journal of physiology. Renal physiology.

[113]  Matthew J. Silva,et al.  Gelsolin Deficiency Blocks Podosome Assembly and Produces Increased Bone Mass and Strength , 2000, The Journal of cell biology.

[114]  E. Clark,et al.  Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells* , 2000, The Journal of Biological Chemistry.

[115]  K. Hruska,et al.  Rho-A Is Critical for Osteoclast Podosome Organization, Motility, and Bone Resorption* , 2000, The Journal of Biological Chemistry.

[116]  M. Le Hir,et al.  Lack of in vivo function of osteopontin in experimental anti-GBM nephritis. , 2000, Journal of the American Society of Nephrology : JASN.

[117]  M. Sy,et al.  Regulation of no synthesis induced by inflammatory mediators in RAW264.7 cells: collagen prevents inhibition by osteopontin. , 2000, Cytokine.

[118]  M. Glimcher,et al.  Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. , 2000, Science.

[119]  W. DeGrado,et al.  The Activation State of αvβ3Regulates Platelet and Lymphocyte Adhesion to Intact and Thrombin-cleaved Osteopontin* , 2000, The Journal of Biological Chemistry.

[120]  K. Chihara,et al.  Parathyroid Hormone-activated Volume-sensitive Calcium Influx Pathways in Mechanically Loaded Osteocytes* , 2000, The Journal of Biological Chemistry.

[121]  T. Nam,et al.  Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth. , 2000, Endocrinology.

[122]  M. Young,et al.  Factor H Binding to Bone Sialoprotein and Osteopontin Enables Tumor Cell Evasion of Complement-mediated Attack* , 2000, The Journal of Biological Chemistry.

[123]  D. Denhardt,et al.  Osteopontin is required for full expression of the transformed phenotype by the ras oncogene , 2000, British Journal of Cancer.

[124]  M. Glogauer,et al.  Intracellular osteopontin is an integral component of the CD44‐ERM complex involved in cell migration , 2000, Journal of cellular physiology.

[125]  Yi-hung Lin,et al.  Coupling of Osteopontin and Its Cell Surface Receptor CD44 to the Cell Survival Response Elicited by Interleukin-3 or Granulocyte-Macrophage Colony-Stimulating Factor , 2000, Molecular and Cellular Biology.

[126]  M. Noda,et al.  Printed in U.S.A. Copyright © 2001 by The Endocrine Society Osteopontin Facilitates Angiogenesis, Accumulation of , 2000 .

[127]  R. Marcus Mechanisms of Exercise Effects on Bone , 2002 .